PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.

Mouse / Crush

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 29211617 ↗2017Reported benefit

Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.

MouseCrushPeripheral-nerve crushC57BL/6Intravitreal and intraperitoneal1 to 10 micromolar intravitreally; 2 to 10 mg/kg intraperit…Intravitreal injection immediately after optic nerve crush

Model: Optic nerve crush

A single intravitreal injection prevented histone deacetylation, heterochromatin formation, apoptosis and DNA damage at 5 and 7 days after crush. Retinal drug concentration after intraperitoneal injection peaked within 1 h then declined rapidly. A single intraperitoneal dose of 2 to 10 mg/kg preven…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.